跳至主要内容
临床试验/CTRI/2025/12/099834
CTRI/2025/12/099834尚未招募不适用

Impact of Nordic Walking as an adjunct to Pulmonary Rehabilitation on Pulmonary Functions, Functional Capacity, Dyspnea and Quality of Life in individuals with Pulmonary Tuberculosis Sequelae

Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2026年1月10日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
64
试验地点
1
主要终点
•Spirometry {Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), Forced Expiratory Volume in 1 second (FEV1)/ Forced Vital Capacity (FVC) ratio}

研究概览

简要总结

This study examines the effectiveness of Nordic Walking as an adjunct to conventional pulmonary rehabilitation in individuals with pulmonary tuberculosis sequelae. Pulmonary TB sequelae often result in persistent airflow limitation, reduced exercise tolerance, increased dyspnea, and compromised quality of life despite completion of medical treatment. Nordic Walking, which incorporates upper-limb involvement using poles, promotes an upright posture, enhances thoracic mobility, and increases engagement of respiratory and peripheral muscles. When combined with standard pulmonary rehabilitation, this walking modality is expected to improve pulmonary function parameters, enhance functional capacity, reduce perceived breathlessness, and positively influence health-related quality of life. The study highlights Nordic Walking as a safe, feasible, and cost-effective exercise strategy that may augment the overall benefits of pulmonary rehabilitation in individuals with post-tuberculosis lung impairment.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • ••Pulmonary Tuberculosis with completed pharmacological treatment before 2 months or more.
  • ••Sputum smear negative.
  • ••Breathlessness modified Medical Research Council (MRC) dyspnea scale grade 2 or higher.

排除标准

  • ••Pneumothorax, hemoptysis, significant secretions, oral lesions or oral bleeding.
  • ••Mentally inadequate and orthopedic problems, gait disorders that could interfere with walking.
  • ••Active smoker.
  • ••Participation in a pulmonary rehabilitation program in the past 12 months.
  • ••Comorbidities involving reduced ability to exercise: significant anemia, electrolyte imbalance or hyperthyroidism.
  • ••Pregnant and lactating women.
  • ••Chronic obstructive pulmonary disease, asthma, interstitial lung disease, cardiovascular diseases such as myocardial infarction, angina and congestive heart failure.
  • ••Unstable angina, myocardial infarction, Resting Heart Rate more than 120 beat per minute.
  • •Systolic Blood Pressure more than 180mmHg, Diastolic BP more than 100mmHg.

结局指标

主要结局

•Spirometry {Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), Forced Expiratory Volume in 1 second (FEV1)/ Forced Vital Capacity (FVC) ratio}

时间窗: At baseline and after completion of 6th week

•Maximum Oxygen Uptake (VO2 max)

时间窗: At baseline and after completion of 6th week

次要结局

  • •modified Medical Research Council scale (mMRC scale)(•Short Form -36 Health Survey (SF-36))

研究者

发起方
Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Urvashi

Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation

研究点 (1)

Loading locations...

相似试验